Literature DB >> 1909195

Immunodepletion of extrinsic pathway inhibitor sensitizes rabbits to endotoxin-induced intravascular coagulation and the generalized Shwartzman reaction.

P M Sandset1, B J Warn-Cramer, S L Maki, S I Rapaport.   

Abstract

We have reported earlier that immunodepletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation (DIC) induced by infusing a low concentration of tissue factor (TF). We now describe the effect of immunodepletion of EPI in rabbits administered endotoxin. Cortisone-treated rabbits were administered anti-rabbit EPI immunoglobulin (IgG) or Fab fragments or were administered control nonimmune material before an injection of endotoxin. In four of seven rabbits administered anti-EPI, plasma EPI activity levels were reduced by 70% to 80% of initial levels for 6 to 8 hours. In these rabbits the endotoxin induced extensive DIC, as evidenced by substantial decreases in fibrinogen, factor V, factor VIII, and platelets, and gross hemorrhagic necrosis of the kidneys due to massive deposition of fibrin in the glomerular microcirculation (the generalized Shwartzman reaction). In three rabbits administered anti-EPI, plasma EPI levels were only transiently reduced. In these rabbits and in four rabbits administered nonimmune IgG or Fab, endotoxin induced minimal to moderate intravascular clotting and deposits of fibrin were not found in the glomerular capillaries. Because it is believed that TF expressed on monocytes triggers endotoxin-induced coagulation, these data are taken as evidence that EPI functions as a natural anticoagulant that can regulate factor VIIa/TF activity expressed on cell surfaces in vivo. They support a hypothesis that EPI prevents thrombotic complications that might otherwise result from exposure of blood to cytokine-induced generation of small amounts of TF on cell surfaces in many inflammatory and infectious disease states.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1909195

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  New biological concepts on coagulation inhibitors.

Authors:  N Sala; J Fontcuberta; M L Rutllant
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

2.  Tissue factor pathway inhibitor in childhood nephrotic syndrome.

Authors:  Mohamed M Al-Mugeiren; Abdel Galil M Abdel Gader; Saud A Al-Rasheed; Abdullah A Al-Salloum
Journal:  Pediatr Nephrol       Date:  2006-03-31       Impact factor: 3.714

3.  Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits.

Authors:  J H Erlich; J Apostolopoulos; T C Wun; K K Kretzmer; S R Holdsworth; P G Tipping
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

4.  Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit.

Authors:  J C Chan; P Carmeliet; L Moons; E D Rosen; Z F Huang; G J Broze; D Collen; F J Castellino
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 5.  Blood coagulation and its alterations in hemorrhagic and thrombotic disorders.

Authors:  S I Rapaport
Journal:  West J Med       Date:  1993-02

Review 6.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

Review 7.  Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis.

Authors:  Steven M Opal; Charles T Esmon
Journal:  Crit Care       Date:  2002-12-20       Impact factor: 9.097

Review 8.  Tissue factor as an initiator of coagulation and inflammation in the lung.

Authors:  Tom van der Poll
Journal:  Crit Care       Date:  2008-11-26       Impact factor: 9.097

9.  Simultaneous expression of tissue factor and tissue factor pathway inhibitor by human monocytes. A potential mechanism for localized control of blood coagulation.

Authors:  M P McGee; S Foster; X Wang
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

Review 10.  Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.

Authors:  Alan E Mast
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-24       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.